Celgene Forms $1B Collaboration With Juno Therapeutics
Biopharmaceutical company Celgene Corp. said on Monday that it is planning a 10-year collaboration with Juno Therapeutics Inc. to work on cancer and autoimmune disease treatments, and will pay Juno about...To view the full article, register now.
Already a subscriber? Click here to view full article